Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-18-045024

Options or other derivatives

  • SVP and Chief Business Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mancilla Bethany SVP and Chief Business Officer 2018-08-01 Grant or award · Stock Option (right to buy) +250,000 250,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…